Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Acar
P1.16-12 Identification of a Biomarker Panel in Resected NSCLC That Predicts Patient Outcomes and Benefit From Adjuvant Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P1.16-47 Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report From ALCHEMIST (Alliance A151216)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ERCC1 as a Biomarker for Bladder Cancer Patients Likely to Benefit From Adjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Polo-Like Kinase 2 Promotes Chemoresistance and Predicts Limited Survival Benefit From Adjuvant Chemotherapy in Colorectal Cancer
International Journal of Oncology
Cancer Research
Oncology
TRAP1 Is a Predictive Biomarker of Platinum-Based Adjuvant Chemotherapy Benefits in Patients With Resected Lung Adenocarcinoma
Biomedical Research
Biochemistry
Medicine
Genetics
Molecular Biology
High TMB Predicts Immunotherapy Benefit in NSCLC
Cancer Discovery
Oncology
P1.09-07 PD-L1 Protein Expression Is a Predictor of Benefit From Adjuvant Chemotherapy in Resected Non-Small Cell Lung Carcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Adjuvant Chemotherapy With Gemcitabine and Long-Term Outcomes Among Patients With Resected Pancreatic Cancer
JAMA - Journal of the American Medical Association
Medicine
P1.16-63 the Value of Adjuvant Chemotherapy in Patients With Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging